$1,400 – $19,500

3rd Global Congress on Antibiotics, Antimicrobials & Resistance (aac) AS

Event Information

Share this event

Date and Time

Location

Location

Venue will be informed to the Registered Participants

TBA

00194 Rome

Italy

View Map

Refund Policy

Refund Policy

No Refunds

Event description
3rd Global Congress on Antibiotics, Antimicrobials & Resistance

About this Event

Theme:

Scrutinizing Modern Research Developments on Antibiotics, Antimicrobial & Antibiotics Resistance

About Conference

With great pleasure, AAC invites all the participants to CPD Accredited: 3rd Global Congress on Antibiotics, Antimicrobials & Resistance” which is slated to held on June 15-16, 2019 at Rome, Italy. This meeting will give the whole focus on existing and most current developments in every aspect of antibiotics and antimicrobial researches. In the light of this subject, this prospect will provide a great stage for discussing among global scientists on antibiotics and its uses. Therefore, the conference committee members warmly welcomes all the prominent researchers, students and delegates to participate in this upcoming antibiotics conference event to witness a valuable scientific discussion and to participate in this session for contributing to the future innovations in this field.

Importance of Attending:

Antibiotics 2020 offers the greatest prospect to encounter eminent speakers and sponsors, network and collaborate with scientists and researchers. Our major focus it to enhance and support the research work, exchange the ideas and methodologies. Students can avail their slot under young researcher forum, the best presenter will be recognized with an memento. Speakers can join with their respective research teams so that they can conduct workshops or symposia during the conference.

Benefits of Attending:

• Networking Opportunities, Grow Your Professional Network

• Meet Experts & Influencers Face to Face

• Break Out of Your Comfort Zone

• Build Your Knowledge Base

• Expand Your connections and resources

• Learning in a New Space

Why to attend?

Antibiotics 2020 is a scientific platform of members from around the world focused on learning about microbes, bacteria, infectious diseases, antibacterial medicines and its advances; this is your best opportunity to reach the largest assemblage of participants from the Healthcare and research community. Present your research via Oral or poster, distribute research information, meet with current and potential scientists or experts in this field, Explore new discoveries in the antibiotics treatment and diagnosis, and receive acknowledgment at this 2-day event. The Discussion of the most current techniques and developments, the latest updates in the health sector, drug resistance and the new therapies to treat diseases are the qualities of this conference.

Reasons to attend:

Antibiotics2020 provides the best opportunity to the great minds working under the field of Pharmacology, Immunology and Life Sciences. Convey your recent research and achievements through oral or poster presentations. Join the global gathering to spread the uniqueness of your research and your new thoughts and opinions and find the solution to progress your career in this field. Dissect the current trending research and update yourself to the latest trends and technologies.

Target Specialties:

• Microbiologist

• Pharmacist

• Quality officers

• Public health officers

• Internal Medicine Specialists

• Family and Primary Care Physicians

• Nurses, Nurse Practitioners

• Hospital and Corporate Administrators and Executives

• Healthcare Students, Scientists, and professors

• Doctors

• Bacteriology Researchers

• Healthcare Associations and Societies

• Pharmaceutical /Medicine Students,

• Life Science scientists

• Pharmaceutical Researchers

• Infection disease physicians

• Pharmaceutics Manufacturing Companies

• R&D Laboratories

Sessions/ Tracks

Session On: Antibiotics and Current Research

Antibiotics are the drug used to treat bacterial infections. Antibiotics has no effect on viral infections. An antibiotic was a substance generated by one microorganism that selectively inhibits the growth of other. Currently, new antibiotics are produced with the potential to treat serious bacterial infections are in clinical development.

Session On: Immunology

Immunology deals with the physical functioning and malfunctions of the immune system like hypersensitivities, allergies, immune deficiency, autoimmune disorders and transplant rejection. The immune system protects us from infections. The failure of immune system functioning can result in diseases like allergy, autoimmunity and cancer. Immune responses contribute a lot to the development of many common disorders.

Session On: Antimicrobial Therapy

An antimicrobial therapy kills or hinders the growth of microbes like bacteria, fungi, or protozoans. Therapies that kill microbes are called microbiocidal therapies and therapies that only inhibit the growth of microorganisms are called microbiostatic therapies. It contributes significantly to the quality of life of many people and reduces the morbidity and mortality due to infectious disease.

Session On: Antibiotics for Emerging & Re-Emerging Diseases

Many new diseases are occurring around the globe and old diseases are re-emerging as Infectious agents that evolve and changes the ecology, socioeconomic conditions, and population patterns. Similarly, many diseases thought to be adequately controlled appear to be making a comeback. So Antibiotics are produced to control this pattern of diseases.

Session On: Drug Discovery Technologies in Antibiotics

Infectious diseases has accounted nearly one fifth of the entire worldwide death toll every year. The constant increase of drug?resistant pathogens is a big challenge for treatment of infectious diseases. In addition, outbreaks of infections and new pathogens are potential threats to public health. The number of newly approved antibiotics has decreased significantly in the last two decades compared with previous decades. In parallel with this, is an increase in the number of drug?resistant bacteria. For these threats and challenges to be countered, new strategies and technology platforms are critically needed. Drug remodelling has emerged as an approach for rapid identification of effective therapeutics to treat the infectious diseases.

Session On: Antibiotic Production and Delivery Method

Antibiotic production can be categorized into three approaches: Natural fermentation, Semi-synthetic, and Synthetic fermentation. As more and more bacteria remain resistant to the produced antibiotics, research and advancement of new antibiotics continues to be essential. In addition to research and advancement into the manufacture of new antibiotics, re-packaging delivery practices is vital to improve the efficacy of the antibiotics that are produced. Enhancements to this field have seen the ability to add antibiotics directly into implanted devices and combination of antibiotics with non-antibiotics to increase the outcomes.

Session On: Chemistry of Antibiotics and mode of action

The process of action is the bio-chemical pathway in which a drug is pharmacologically efficient. This can be a precise target where the drug binds like an enzyme, as is the case with many antibiotics, or a receptor. Mechanism of action explains the biochemical process particularly at a molecular level.

Session On: Microorganisms Producing Antibiotics

Microbes produces the product called the bioactive secondary microbial metabolites and this product from the micro-organism is used to produce the Antibiotics. The major producers of the microbial metabolite are the actinobacteria, fungi and other filamentous bacteria which represent inexhaustible sources for the future. The increasing taxonomic, chemical and bio-diversities of microbial metabolites certainly will give numerous new leads and drugs and other products not only for the chemotherapy but in other fields of human therapy and also for the agriculture to treat and sustain the increasing population.

Session On: Antimicrobial Peptides

Antimicrobial peptides or proteins (AMPs) are a distinct class of naturally occurring particles that are produced as a first line of defence by all multicellular organisms. These proteins can have wide activity to directly destroy/kill bacteria, yeasts, fungi, viruses and even cancer cells. These peptides/proteins are potent, wide-ranging spectrum antibiotics which proves the potential as novel therapeutic agents.

Session On: Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs

The pharmacodynamics of an antimicrobial drug correlates its pharmacokinetics to the time course of the antimicrobial effects at the site of the infection. This track mainly focus on pharmacokinetics, antimicrobial pharmacodynamics, the effect of pharmacodynamics on the emergence of resistant bacterial sub-populations and the development of pharmacodynamics breakpoints for use in the design of trials of these drugs and in the treatment of infected patients.

Session On: Antibiotics and Clinical Trials

There has been an increasing use of antibiotics in all areas of medicine. Clinical trials are used to test antibiotics which are normally of a less than satisfactory quality. The main objective of initial clinical trials, at least, is to provide the pharmaceutical company with sufficient information to persuade the regulatory authority that the drug is effective, safe and well produced.

Session On: Paediatric Antibiotics

Prescription of antibiotics for children is a scrupulous act. Side effects from antibiotics are a frequent reason that children go to the emergency room. The drugs can cause diarrhoea or vomiting and about 10 out of 100 children have allergies to them. Some of these allergic outcomes can be serious and create life threatening problems.

Session On: Veterinary Antibiotics

Antibiotic drugs are frequently used in veterinary treatment to cure the infectious diseases that are caused by bacteria and certain other microbes. There are many different classes of antibiotics available for use in animals where some are effective against a wide range of organisms, while others are more closely targeted. When given a prescription from your veterinarian for your pet, make sure that it is given exactly as instructed and that the entire prescription is given. Not following dosage programs or not giving all of the prescription can cause a relapse or a reinfection or development of antibiotic-resistant organisms. This session is about using specific and appropriate supportive treatment to enhance the animal’s ability to overcome the infection and associated illness conditions.

Session On: Oncology Antibiotics

Laboratory-produced drugs used to target and destroy cancerous cells. Therapeutic anticancer antibiotics have become an accepted treatment for certain types of cancer. These drugs bind specifically to primary and metastatic cancer cells to block cell growth, while limiting effects on surrounding healthy cells. Antibiotic medicines kill malignant cells by fragmenting the DNA in the cell nucleus and by oxidizing critical compounds which are necessary for the cell. For patients receiving chemotherapy, there is an heightened risk of infection due to a low white blood cell count (neutropenia) triggered by a toxic effect of chemotherapy on the bone marrow. Preventive antibiotic therapy before the development of fever prevents illness and death in people with a low white blood cell count after chemotherapy.

Session On: Generic Antibiotics

Generic drugs reduce drug costs and thereby national medical expenses. Because generic drugs provide benefits for both public administration and consumers, it is expected that they will be more broadly used in the future. The session is open to drug components, levels of impurity, pharmacokinetics, pharmacokinetic/pharmacodynamics relationship, in vitro effectiveness, therapeutic effectiveness in experimental models, marketing authorization of generic antibiotic drugs.

Session On: Alternatives to Antibiotics

The antibiotic resistance problem is triggered by the evolution and transmission of genes that confer resistance to medically essential antibiotics into human pathogens. The acquisition of such resistance genes by pathogens complicates the disease treatment, increases health care costs, and also increases the morbidity and mortality in humans and animals. As antibiotic resistance persists to evolve, antibiotics of so-called last resort developed even more precious. Reducing or avoiding the dissemination of antibiotic resistance genes into human pathogens is presently of high international importance. This session is open to Antibiotic prudency, bacteriophage therapy, predatory bacteria, bacteriocins, and competitive exclusion of pathogens, Immunotherapeutics, Antibodies, Vaccines and gut microbiota modulation.

Session On: Interaction and side-effects of antibiotics

Basic reactions connected with anti-microbial incorporate loose bowels, heartburn and bloating, loss of craving and feeling debilitated, as indicated by NHS Choices. Antibiotic medications increment skin affectability to both common and simulated light. Anti-infection utilize can disturb the variations of microbes in the body, causing vaginal diseases in women and bringing on agitated stomach. Abuse of antibiotics can prompt to bacterial resistance. More side effects include Nausea, vomiting, headache, fever and swelling of face too.

Session On: Occupational health issues for infection prevention

Antibiotics are strong medicines that treat bacterial infections. Common illnesses caused by bacteria are urinary tract infections, strep throat, pneumonia and more. Antibiotics can treat bacterial infections by killing the bacteria that causes them. Tetracycline is often used to treat acne and rosacea. Sulfonamides used to treat UTIs, bronchitis, eye and ear infections, pneumonia and bacterial meningitis. Cephalosporin can be used to treat UTIs, ear and skin infections, respiratory infections, bacterial meningitis, and sepsis. Overuse of antibiotics results growth of resistance bacteria which cannot react to previously used antibiotics and this becomes a widespread problem for the public health.

Session On: Antibiotics: Market Analysis & Business Opportunities

Antibiotics can be used in non-medical industries. They are mainly used in animal husbandry, bee-keeping; fish farming and other forms of aquaculture, ethanol production, horticulture, antifouling paints, food preservation and many more.

Session On: Next Generation Approaches

The increasing fear of drug-resistant pathogens is leading to a growing push for the next generation of antibiotics. The enhancement of new antibiotics is crucial to control the current and future infectious diseases caused by antibiotic-resistant bacteria. The discovery of a new antibiotic called teixobactin was revealed by international team of researchers in 2017. The researchers now intend on analyzing the bacteria and decide what tools might be able to control its behaviour to release its full antibiotic potential. An expected 5–10% of all hospitalizations are perplexed by a nosocomial disease with an expected cost of $4.5–5.7 billion every year in the USA alone. More kinds of biological solution are yet to be discovered in this field.

AGENDA & SPEAKER

Coming Soon!

"Please contact the event manager Marilyn (marilyn.b.turner@nyeventslist.com ) below for:

- Multiple participant discounts

- Price quotations or visa invitation letters

- Payment by alternate channels (PayPal, check, Western Union, wire transfers etc)

- Event sponsorships

NO REFUNDS ALLOWED ON REGISTRATIONS

Service fees included in this listing.

-----------------------------------------------------------------

Allied Academies - New York Events List

http://www.NyEventsList.com

http://www.BostonEventsList.com

http://www.SFBayEventsList.com

-----------------------------------------------------------------

MYL191021CEV JSM200128UPT

Share with friends

Date and Time

Location

Venue will be informed to the Registered Participants

TBA

00194 Rome

Italy

View Map

Refund Policy

No Refunds

Save This Event

Event Saved